Bispecific BCMA/CD19 targeted CAR-T cell therapy forces sustained disappearance of symptoms and anti-acetylcholine receptor antibodies in refractory myasthenia gravis: a case report

Saved in:
Bibliographic Details
Published in:Journal of neurology 2024-07, Vol.271 (7), p.4655-4659
Main Authors: Zhang, Yong, Liu, Dan, Zhang, Zhouao, Huang, Xiaoyu, Cao, Jiang, Wang, Gang, Du, Xue, Wang, Zhouyi, Yang, Mingjin, Luo, Tiancheng, liu, Sha, Zhang, Wan, Sheng, Ying, Li, Huizhong, Zhang, Wei, Chen, Hao, Zhang, Shenyang, Wang, Xiaopeng, Meng, Wenqing, Zong, Shenghua, Shi, Ming, Zheng, Junnian, Cui, Guiyun
Format: Article
Language:English
Subjects:
Acetylcholine receptors
CD19 antigen
Cell therapy
Letter to the Editors
Lymphocytes T
Medicine
Medicine & Public Health
Myasthenia gravis
Neurology
Neuromuscular junctions
Neuroradiology
Neurosciences
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0340-5354
1432-1459
1432-1459
DOI:10.1007/s00415-024-12367-4